Cargando…
No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions
Patients with Addison’s disease have relatively high rates of depression and anxiety symptoms compared with population-based reference samples. Addison’s disease results in deficiency of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S). There is considerable debate about the specific effects...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425479/ https://www.ncbi.nlm.nih.gov/pubmed/28553251 http://dx.doi.org/10.3389/fpsyg.2017.00764 |
_version_ | 1783235308894027776 |
---|---|
author | Heald, Adrian H. Walther, Andreas Davis, Julian R. E. Moreno, Gabriela Y. C. Kane, John Livingston, Mark Fowler, Helen L. |
author_facet | Heald, Adrian H. Walther, Andreas Davis, Julian R. E. Moreno, Gabriela Y. C. Kane, John Livingston, Mark Fowler, Helen L. |
author_sort | Heald, Adrian H. |
collection | PubMed |
description | Patients with Addison’s disease have relatively high rates of depression and anxiety symptoms compared with population-based reference samples. Addison’s disease results in deficiency of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S). There is considerable debate about the specific effects of DHEA deficiency on energy level and mood. We measured emotional well-being in 16 patients with Addison’s disease and a group of 16 hospital attendees with type 2 diabetes. Participants completed the General Health Questionnaire-28 (GHQ-28), the Hospital Anxiety and Depression Scale (HADS), the World Health Organization’s quality of life assessment (WHOQOL-BREF) and the Holmes–Rahe life event scale. DHEA-S was low in Addison’s patients (Addison’s men: 0.5 ± 0.1 μmol/l [normal range: 2.1–10.8] compared with diabetes men: 3.2 ± 1.2 μmol/l; Addison’s women: 0.4 ± 0.01 μmol/l [normal range: 1.0–11.5] compared with diabetes women: 2.2 ± 0.71 μmol/l). Testosterone levels were similar in both groups studied. There were no differences in emotional well-being and quality of life (QOL) between patients with Addison’s disease and Type 2 Diabetes Mellitus as measured by GHQ-28 (Addison’s: 22.4 ± 2.6, Diabetes: 19.6 ± 2.7), HADS Depression (Addison’s: 5.4 ± 0.9, Diabetes: 4.5 ± 1.4), HADS Anxiety and WHOQOL-BREF. There were no gender differences in affective symptomatology within the Addison’s group. Life event scores were above average in both groups (Addison’s: 195 ± 39.6, Diabetes: 131 ± 43.8), but not significant for difference between groups as was GHQ-28 total score. Both groups scored highly on the GHQ-28 and the life event scale, indicative of poorer health perceptions than the general population. This could be due to the chronicity of both disorders. We have not identified any specific effects of DHEA-S deficiency on mood or QOL. |
format | Online Article Text |
id | pubmed-5425479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54254792017-05-26 No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions Heald, Adrian H. Walther, Andreas Davis, Julian R. E. Moreno, Gabriela Y. C. Kane, John Livingston, Mark Fowler, Helen L. Front Psychol Psychology Patients with Addison’s disease have relatively high rates of depression and anxiety symptoms compared with population-based reference samples. Addison’s disease results in deficiency of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S). There is considerable debate about the specific effects of DHEA deficiency on energy level and mood. We measured emotional well-being in 16 patients with Addison’s disease and a group of 16 hospital attendees with type 2 diabetes. Participants completed the General Health Questionnaire-28 (GHQ-28), the Hospital Anxiety and Depression Scale (HADS), the World Health Organization’s quality of life assessment (WHOQOL-BREF) and the Holmes–Rahe life event scale. DHEA-S was low in Addison’s patients (Addison’s men: 0.5 ± 0.1 μmol/l [normal range: 2.1–10.8] compared with diabetes men: 3.2 ± 1.2 μmol/l; Addison’s women: 0.4 ± 0.01 μmol/l [normal range: 1.0–11.5] compared with diabetes women: 2.2 ± 0.71 μmol/l). Testosterone levels were similar in both groups studied. There were no differences in emotional well-being and quality of life (QOL) between patients with Addison’s disease and Type 2 Diabetes Mellitus as measured by GHQ-28 (Addison’s: 22.4 ± 2.6, Diabetes: 19.6 ± 2.7), HADS Depression (Addison’s: 5.4 ± 0.9, Diabetes: 4.5 ± 1.4), HADS Anxiety and WHOQOL-BREF. There were no gender differences in affective symptomatology within the Addison’s group. Life event scores were above average in both groups (Addison’s: 195 ± 39.6, Diabetes: 131 ± 43.8), but not significant for difference between groups as was GHQ-28 total score. Both groups scored highly on the GHQ-28 and the life event scale, indicative of poorer health perceptions than the general population. This could be due to the chronicity of both disorders. We have not identified any specific effects of DHEA-S deficiency on mood or QOL. Frontiers Media S.A. 2017-05-11 /pmc/articles/PMC5425479/ /pubmed/28553251 http://dx.doi.org/10.3389/fpsyg.2017.00764 Text en Copyright © 2017 Heald, Walther, Davis, Moreno, Kane, Livingston and Fowler. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychology Heald, Adrian H. Walther, Andreas Davis, Julian R. E. Moreno, Gabriela Y. C. Kane, John Livingston, Mark Fowler, Helen L. No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions |
title | No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions |
title_full | No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions |
title_fullStr | No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions |
title_full_unstemmed | No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions |
title_short | No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions |
title_sort | no difference in mood and quality of life in dhea-s deficient adults with addison’s disease vs. type 2 diabetes patients with normal dhea-s levels: implications for management of these conditions |
topic | Psychology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425479/ https://www.ncbi.nlm.nih.gov/pubmed/28553251 http://dx.doi.org/10.3389/fpsyg.2017.00764 |
work_keys_str_mv | AT healdadrianh nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions AT waltherandreas nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions AT davisjulianre nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions AT morenogabrielayc nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions AT kanejohn nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions AT livingstonmark nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions AT fowlerhelenl nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions |